-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Marker Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Marker Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.4M, a 25% increase year-over-year.
- Marker Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$10.2M, a 3.32% increase year-over-year.
- Marker Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$14.6M, a 26.3% increase from 2022.
- Marker Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$19.8M, a 49.9% increase from 2021.
- Marker Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$39.5M, a 36.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)